Decellularized Extracellular Matrix (ECM)

 Bovine pericardium decellularized extracellular matrix, processed to remove cellular components while preserving native ECM architecture -  providing a biocompatible scaffold for research and tissue-engineering applications.

Bovine pericardium: Sourced from closed-herd cattle in WOAH controlled-BSE-risk regions; animal age restricted to <30 months. ISO 22442-2:2020 sourcing controls; full material traceability.

Processing

• No aldehyde chemistry — decellularized, non-crosslinked
• Removes cellular components and DNA while preserving the ECM
• Designed to retain native collagen and elastin architecture

• Non-immunogenic processing target; residual DNA reduced to <10 ng/mg
• Smooth (serous) and villous (fibrous) surfaces
• Thickness range 0.15-0.75 mm
• Suturable; handles similarly to native tissue

5×5, 6×8, 5×10, 8×4, 8×8, 6×12, 10×10, 12×10 cm. Custom sizes on request.

• Scaffolds for cell culture - 3-D substrates for cell/tissue engineering
• Direct scaffolds, targeted-delivery scaffolds, and tissue-engineered constructs
• Evaluation of surgical techniques and device development in non-clinical settings

 SokoLife's decellularized ECM in its research-use configuration is supplied for laboratory research, tissue-engineering, educational, training, and veterinary use only. It is not a finished medical device and is not intended for human clinical use in this configuration.

Clinical configurations of SokoLife's decellularized bovine pericardium ECM are in development and under FDA 510(k) submission preparation. They have not been cleared or approved by the FDA and are not available for clinical sale in the United States. Clinical-application descriptions reflect indications under investigation, not cleared claims.